Hoth Therapeutics HOTH

$ 0.84 2.0%

Quarterly report 2024-Q3
added 11-12-2024

Hoth Therapeutics Financial Statements 2011-2024 | HOTH

Annual Financial Statements Hoth Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	5.18 M	2.45 M	506 K	26.1 M	43.1 M	-	-	-	-	-	-	-	-
Shares	3.41 M	1.2 M	893 K	12.4 M	9.16 M	-	-	-	-	-	-	-	-
Historical Prices	1.52	2.05	0.567	2.11	4.7	-	-	-	-	-	-	-	-
Net Income	-7.85 M	-11.4 M	-14.3 M	-7.2 M	-7.7 M	-2.5 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-7.69 M	-11.1 M	-14.1 M	-7.3 M	-7.71 M	-2.5 M	-	-	-	-	-	-	-
Interest Expense	-	451 K	-59.6 K	104 K	-	-	-	-	-	-	-	-	-
EBITDA	-7.69 M	-11.1 M	-14.1 M	-7.3 M	-7.71 M	-2.49 M	-	-	-	-	-	-	-
Operating Expenses	7.69 M	11.1 M	14.1 M	7.3 M	7.71 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	1 M	6.13 M	-	3.96 M	5.06 M	1.22 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Hoth Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	6.9 M	6.88 M	4.4 M	4.35 M	3.48 M	3.3 M	2.48 M	1.3 M	1.29 M	1.24 M	959 K	959 K	956 K	23.7 M	17.7 M	13.4 M	13.4 M	12.3 M	10.3 M	10.1 M	9.89 M	9.6 M	7.01 M	5.07 M	5.08 M	5.04 M	4.93 M	4.71 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-2.13 M	-1.63 M	-2.04 M	-	-2.09 M	-1.87 M	-2.18 M	-	-2.64 M	-2.68 M	-2.57 M	-	-3.3 M	-3.28 M	-4.26 M	-	-2.12 M	-2.5 M	-1.83 M	-	-1.7 M	-1.27 M	-829 K	-	-620 K	-763 K	-528 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	1.24 B	-	-	-	-	-	-	-	-	-	-	-	-	-	8	2	6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-2.13 M	-1.65 M	-2.05 M	-	-2.09 M	-1.71 M	-2.19 M	-	-2.68 M	-2.3 M	-2.66 M	-	-3.25 M	-3.2 M	-4.27 M	-	-2.17 M	-2.52 M	-1.82 M	-	-1.7 M	-1.27 M	-829 K	-	-620 K	-763 K	-528 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	786	-	-	-	-592	-262	41.7 K	-	-29.1 K	-19.5 K	-12 K	-	49.9 K	18.3 K	-10.1 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-2.68 M	-2.3 M	-2.66 M	-	-3.25 M	-3.2 M	-4.27 M	-	-2.17 M	-2.52 M	-1.82 M	-	-1.7 M	-1.27 M	-829 K	-	-619 K	-763 K	-527 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	2.13 M	1.65 M	2.05 M	-	2.09 M	1.71 M	2.19 M	-	2.68 M	2.3 M	2.66 M	-	3.25 M	3.2 M	4.27 M	-	2.17 M	2.52 M	1.82 M	-	1.7 M	1.27 M	829 K	-	620 K	763 K	528 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.23 M	1.08 M	327 K	-	67.1 K	46.2 K	1.25 M	-	-	238 K	-	-	-	219 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency